DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Abrahami D, Douros A, Yin H. et al.
Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.
BMJ 2018;
360: k872
We do not assume any responsibility for the contents of the web pages of other providers.